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Abstract 
The posterior fossa arteriovenous malformation (AVM) is uncommon and different from other intracranial AVM in its natural 
history, diagnosis, treatment, prognosis, and other features. Authors present a review of the actual procedures of diagnosis and 
treatment in the field of infratentorial cerebral arterio-venous malformations, based on the actual literature data. Pre-therapeutic 
considerations, such as clinical presentation and diagnostic evaluation, are initially discussed because they are crucial in choosing 
the optimal treatment. Posterior fossa AVMs merit multimodality intervention when feasible in most cases because of their higher risk 
of rupture and higher potential of morbidity and mortality. In addition, we present two significant cases treated in our department. 
 
Keywords: arteriovenous malformation; infratentorial location, posterior fossa,  
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Introduction  
Clingenstein [43] first reported Infratentorial 
arteriovenous malformations as a clinical entity in 1908, 
and, Olivecrona and Rives have reported the first 
successful resection of a posterior fossa AVM in 1932 
(24). 
Although relatively rare lesions, infratentorial AVMs 
caused a great interest within the neurosurgical 
community. Significant efforts have been made for a 
better understanding of anatomic and hemodynamic 
complexity of these lesions, to facilitate more effective 
treatment strategies.  
Despite the marked emergence of microsurgical 
techniques, which have become more refined in the last 
half century, excision of posterior fossa AVMs is a 
formidable quest. The difficulty of treatment of these 
lesions, in terms of surgery, lies in the need for 
preservation of critical neurovascular structures within or 
around the brainstem and cerebrum, and the need for 
preservation of cranial nerve and deep brainstem nuclei, 
plus technical difficulties caused by the narrow surgical 
corridor, especially for deep lesions [28,31,35]. 
Accumulating experience with the treatment of posterior 
fossa AVMs and the incorporation of multimodality 
approaches, including radiosurgery, endovascular 
therapy, and improved microsurgical techniques, have 
significantly contributed to continuously improving 
outcomes [23,34]. 
Success of treatment mainly depends on advanced 
medical technology, namely: digital subtraction 
angiography, MRI angiography, neuroradiologic 
interventional procedures, intraoperative monitoring, 
neuronavigation, neuroanesthesia, with controlled 
hypothermia, the use of neurosurgical microinstruments, 
and the existence of a radiosurgical department.   
Diagnosis and clinical manifestations 
Natural History. Posterior fossa AVMs account for 
only 5-7% of all intracranial AVMs. With the advances of 
modern neuroimaging, the frequency rate of posterior 
fossa AVMs grew to 10-15% [1,2,6,7]. The incidence of 
posterior fossa AVMs at autopsy is even higher, reaching 
20% of all intracranial AVMs. 
Infratentorial AVMs may be located within 
cerebellum, brainstem or both. McCormick [19] has 
published a study of 104 cases of infratentorial AVMs, in 
which 69 were located within the brainstem, most 
commonly in the ponts. Batjer and Samson [2] showed 
that two thirds of the posterior fossa AVMs are located 
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within the cerebellum, 20% in the brainstem and 20% in 
both cerebellum and brainstem. 
Bleeding is the most common form of presentation 
of posterior fossa AVMs  [3,10,21,38]. In most clinical 
series the incidence of subarachnoid or 
intraparenchimatal bleeding was reported to be between 
75 and 92% [13,25,26]. Recent studies have suggested 
that brainstem AVMs presentation is less common with 
bleeding than cerebellum AVMs. Accumulating data have 
demonstrated an independent association of infratentorial 
AVM location and hemorrhagic presentation [13,26,41]. 
This is alarming in light of the considerably greater 
morbidity and mortality associated with posterior fossa 
AVM rupture [12]. Fortunately, with accumulating surgical 
experience and the cultivation of multimodality  AVM 
therapy, therapeutic success continues to improve [25]. 
Posterior fossa AVMs were frequently associated with 
aneurysms (25%) on the feeding arterial pedicles of the 
nidus and were often the cause of hemorrhage [20,22,39]. 
Progressive neurological deficits (including those 
secondary to mass effect, ischemia, and hydrocephalus) 
were the second most common mode of presentation 
[37]. Cranial nerve palsies, often affecting the trigeminal 
nerve, have been associated with lesions of the 
cerebellopontine angle and brain stem [6]. Headache, a 
relatively non-specific symptom, can occur in as many as 
10% of the patients diagnosed with unruptured AVMs [2]. 
At the time of detection, at least 15% of people affected 
by AVMs are asymptomatic [30]. The incidence of 
asymptomatic posterior fossa AVMs may rise in the future 
with the increasing use of advanced neuroimaging 
modalities for nonspecific symptomatology [25] 
Complete neuroradiological evaluation of AVMs 
includes cerebral computer tomography (CT) with contrast 
administration, magnetic resonance imaging (MRI) and 
angio-MRI, cerebral angiography with substraction. 
Because the posterior fossa AVMs present with 
acute symptoms, the initial diagnostic test is usually 
computer tomography (CT) scan. Brain CT-scan is a 
first diagnostic neuroimaging of either the AVM itself, of 
intraparenchimatal hematoma secondary to malformation 
rupture, or subarachnoid or intraventricular bleeding. 
Brain CT-scan, with or without contrast is the screening 
procedure of unruptured posterior fossa AVMs: grouped 
serpentine veins and dilated arteries, and, sometimes, 
large drainage veins may be revealed, elements that 
highly suggest the diagnosis of AVM. CT-scan may 
provide information regarding location, extent and size of 
the AVM, but the value of CT-scan is limited regarding 
diagnosis and anatomical evaluation of AVM, when 
compared to angiography and magnetic resonance 
imaging. 
Magnetic resonance imaging (MRI) combined 
with angio-MRI allows specific diagnosis in most cases 
with AVMs. Information provided by MRI exam 
supplement those provided by angiography, improving the 
tridimensional definition of AVM.  
Angio-MRI allows multiplanar evaluation of the 
AVM, but does not identify all feeding arteries and 
drainage veins of the complex AVMs [33]. In order to 
identify feeding arteries, selective arterial angio-MRI for a 
single arterial branch can be used to evaluate drainage 
veins MRI venography. Moreover, sensory "phase 
contrast" technique may be associated and can be used 
to reveal slow flow. Angio-IRM is useful (together with 
conventional MRI, which more accurately reveals the 
AVM topography) in planning surgical treatment, 
embolization or irradiation with gamma-knife of the AVM, 
however, it is insufficient.  
Posterior fossa AVM functional MRI [15], helps to a 
more precise delineation of target volume for radiosurgery 
(although it is more useful in supratentorial lesions 
compared to subtentorial ones). Functional MRI also 
allows study of brain functions reorganization and 
postoperative recovery.  
Gold-standard diagnosis is represented by 
angiography, and if necessary, stereo-angiography. It is 
the most useful and sensitive method to identify and 
evaluate the AVMs (provides the richest information 
regarding nidus characteristics, feeding and drainage 
vessels), and to highlight the operatory planning of the 
AVM. All patients must undergo formal six-vessel catheter 
angiography for accurate characterization of the anatomy 
and hemodynamics of the AVM. In particular, all feeding 
arteries and draining veins must be diligently identified 
preoperatively, in the preparation for a complete 
resection. High-resolution magnification studies are 
required for both VAs, both internal carotid arteries, and 
both external carotid arteries, because approximately 
10% of infratentorial AVMs are fed by one or both external 
carotid arteries [27,31,32]. No other investigation cannot 
replace conventional DSA angiography in therapeutic 
decision.  
Optionally, exploration of cerebral hemodynamics 
can be done by: positron emission tomography (PET) or 
SPECT.  
Intraoperative ultrasonography is useful to 
highlight any remaining portion of the AVM, but also to 
test the functionality of the remaining blood circulation 
after cliping.  
Treatment options 
The main goal of treatment is complete cure of 
the lesion and prevents the risk of bleeding with restoring 
normal brain flow. It is considered that the complete 
absence of AVM on postoperative angiography eliminates 
the risk of secondary hemorrhage. 
The choice of treatment for patients should consider risks 
attendant to each therapeutic option, as well as the 
natural history of the individual patient [18]. Current 
treatment methods include radiosurgery, open surgery, 
endovascular embolization and combination of them. 
Occasionally, patients with asymptomatic AVMs may not 
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be treated but should be followed clinically on an annual 
or semiannual basis  [34]. Treatment should be 
individualized for each patient and should be undergone 
by a multidisciplinary team. 
Most neurosurgeons prefer to leave the small, 
unruptured malformations, located in eloquent areas or in 
elderly patients, for radiosurgery. AVMs under 3 cm in 
diameter, located in non-eloquent areas are fit for surgery. 
Small, ruptured AVMs, located in eloquent areas, which 
have caused neurological deficits, are treated with open 
surgery. 
Surgery for medium and large AVMs depends on a 
series of objective factors mentioned above but also on 
subjective factors (department’s tradition, neurosurgeon’s 
experience, family desire, etc.) 
Ruptured AVMs with hematomas, prone to causing 
brain herniation, require emergent surgery, as a first step, 
in order to evacuate the hematoma, the angiography and 
the curative surgery are done later. 
Patients with major deficits, which occurred after 
rupture of malformations, but without imminent herniation 
can be treated conservatively, until neurological 
stabilizing, followed by reevaluation and surgery. 
Patients with large, unruptured, oligosymptomatic 
AVMs, located in eloquent areas, carrying particularly 
high-risk for surgery are treated conservatively and 
followed-up. 
With the sole exception of very small AVMs, 
embolization is beneficial before surgical treatment of 
most AVMs in the posterior fossa. 
Each of the above mentioned methods have several 
limitations: 
1.  surgery cannot resolve deep anatomical 
lesions or patients presenting with altered 
neurological status. 
2.  radiosurgery has a high rate of 
complications in AVMs larger than 3cm. 
3.  embolization is not a radical cure, except for 
5-10% of cases, but it can proceed in an 
open surgery in giant AVMs, or 
radiosurgery; it can treat AVM-associated 
aneurysms and arteriovenous fistulae from 
plexiform malformations. 
Analysis of late results of different treatment 
combinations is demanding and requires long-term 
angiography: embolization carries the risk of 
revascularization and radiosurgery has a delayed action. 
 
Pre-therapeutic considerations 
The next three steps must be rigorously taken 
when evaluating each case: 
1.  Comparisons between treatment risks and 
risk required by the natural history of 
disease 
2.  Evaluation of the patients’ age, 
comorbidities, pregnancy in women, 
assessing the location of the lesion with 
extensive anatomical details including 
venous drainage, which are the guiding 
factors for therapy selection. 
3.  Comparison of risk factors between different 
procedures or combinations of procedures. 
Therapeutic decision requires a thorough 
knowledge of the risks and benefits of different options, in 
such a way that the patient receives the best choice. 
Choosing the optimal treatment depends on the 
clinical condition, size, location and angio-architecture of 
the AVM, patient’s age, comorbidities, and treatment 
possibilities of the team. The treatment method chosen 
must have a lower risk than the natural history of the 
disease, involving a bleeding rate of 6-15% per year for 
posterior fossa AVMs [3,8,9,11,42].  
 
Grading Systems and Risk of Therapy 
Angiography allows assessment of AVM’s angio-
architecture and hemodynamic situation entirely. Even 
medium AVMs (3-6 cm) can have multiple compartments 
requiring supraselective angiography necessary to adopt 
optimal intraoperative strategy. 
It is important to specify: the presence of high flow, 
plexiform components, multiple feeding arteries, presence 
of lenticulostriat feeding arteries, which must be 
preserved during surgery, presence of aneurysms located 
into the nidus or on feeding arteries, venous drainage, 
which can sometimes flow extensively through the skull, 
endangering the craniotomy. 
Martin-Spetzler scale [36] was adopted in 1986 and 
it is a widely used therapeutical decision-making tool 
which gives information about the risk assessment of 
postoperative neurological deficit in AMVs. 
 
Size of AVM  Points assigned    
< 3 cm - small AVM  1 
3-6 cm - medium AVM   2 
> 6 cm - large AVM  3 
Eloquent adjacent brain  0 
Noneloquent  1 
Eloquent  0 
Venous drainage  1    
Superficial  Points assigned    
Profound  1 
 
The grading of AVM is given by the sum of points 
assigned for size, eloquence and venous drainage. 
The higher the malformation, the higher the 
intraoperative risks are, hyperperfusion syndromes occur 
more frequently and the risk of postoperative deterioration 
becomes more serious. 
The risk of postoperative neurological deficits for 
small lesions is 5.1%, for medium AVMs is 21.5% and for 
large ones it reaches 40%. Deep venous drainage, adds a 
plus of 20% in permanent neurological deficits. 
It is generally considered that patients with AVMs of 
grades I, II and III benefit from surgical resection and 
those with grades IV and V have major risk of permanent 
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neurological deficits. Grade VI patients are considered 
inoperable. 
However, in certain situations, resection carries an 
unacceptable risk of injury to the patient. 
Contraindications of surgical removal include brainstem 
AVMs that do not present to the pial surface, cerebellar 
AVMs that involve the deep cerebellar nuclei, poor 
neurological or medical condition of the patient, and 
advanced age. [34] 
 
Surgical Treatment 
Arteriovenous malformations of the infratentorial 
space pose a unique technical challenge for 
neurovascular surgeons. Until recently, the surgical risk of 
resection of arteriovenous malformations in this location 
was considered unacceptable. However, despite the 
increasing experience and the refinements in surgical and 
anesthetic techniques, procedures once considered to 
court disaster can now be achieved with acceptable 
morbidity rates [4,31]. Successful removal of posterior 
fossa AVMs requires an intimate knowledge of the 
architecture of the malformations, the surrounding 
anatomical structures, and their involved relationships (4). 
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Because most posterior fossa AVMs present with 
intraparenchymal hemorrhage, the initial surgical focus is 
directed to hematoma removal and treatment of any acute 
mass effect or hydrocephalus, if it is present. When 
feasible, however, definitive resection of the AVM should 
be deferred for 4 to 6 weeks. In this manner, delayed 
extirpation often ensures sufficient time for brain swelling 
to diminish and the hematoma to liquefy, features that 
greatly facilitate ultimate AVM excision. Late treatment is 
also beneficial in that associated cerebral aneurysms, 
which might initially have been obscured by 
intraparenchymal hemorrhage on the first angiogram, and 
could later be clearly visualized after a brief period of 
quiescent. On rare occasions, a patient who needs early 
hematoma evacuation may require complete AVM 
resection during the same operation because of 
intraoperative hemorrhage. In such a situation, every 
effort is made to preserve all viable cerebellar tissue as 
well as alleviate any undue mass effect on the brainstem. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Basic principles for surgical treatment of posterior 
fossa AVMs are similar to those for treatment of AVMs 
with any other intracranial location [27]. The principles of 
optimal patients positioning, adequate bony exposure, 
extensive dural opening, meticulous attention to sharp 
microdissection, and compulsive hemostasis are critically 
important during surgical resection of posterior fossa 
AVMs [4,16]. 
 
 
 
 
 
 
  There are neurosurgeons who prefer to operate all 
types of AVMs. Most neurosurgeons recommend surgery 
with resection of infratentorial AVMs, as the treatment of 
choice (excluding patients with comorbidities, that 
increased surgical risk of patients over 70 years old), due 
to the high morbidity associated with bleeding in the 
posterior fossa [34,38]. With the help of modern 
microsurgical instruments, the modern means of 
neuroprotective neuroanesthesia (heart stopping and 
extracorporeal circulation, deep hypothermia with the 
central body temperature of 15 degrees Celsius for a 
maximum period of time of 50 minutes of work), MAV 
located in cerebellum, subarachnoid cisterns, and pial 
surfaces of the brainstem may be successfully treated 
surgically with excellent results in most cases.  [27,34]. 
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Fig. 1k  Fig. 1j 
Fig. 1. A 19-year-old woman admitted in comatose state found to have cerebellar AVM: (a),(b),(c) axial CTscan demonstrating 
vermian hemorrhage with important surrounding edema, intraventricular bleeding within the third and forth ventricle, massive 
infratentorial subarachnoid hemorrhage and acute hydrocephalus;(d),(e) left vertebral angiogram and (f),(g) right vertebral 
angiogram showed an infratentorial AVM, located within the right cerebellar hemisphere, with a nidus, measuring around 3 cm – 
the maximal diameter in the craniocaudal direction with arterial feeders from the right posterior cerebral artery and superior 
cerebellar artery and venous drainage into the Galen vein, Herophil torculla, and right lateral sinus; (h),(i),(j),(k) postoperative 
angiographic studies obtained in the same patient: anteroposterior and lateral projections reveal complete resection of the 
cerebellar AVM and excellent flow through the vertebrobasilar circulation. 
 
 
Endovascular Treatment  Because embolization is an adjunct to surgical 
resection of the lesion, embolization should be primary 
focused on various large feeding arteries or arteries 
difficult to be found early during surgery. In large 
cerebellar AVMs the feeding arteries come from PICA. 
Preoperative embolization of these arteries was shown to 
lower blood flow through the nidus. Because PICA is 
relatively quickly exposed during surgery, proximal 
embolization of PICA is not needed, because of the high 
risk of cerebellum or brainstem stoke. 
The goal of embolization is to permanently reduce 
the size of malformations and abnormal blood flow 
thereby, reducing the incidence of secondary bleeding, 
and favoring other curative procedures, surgical or 
radiosurgical, with minimum risks for the patient.  
Current indications for embolization can be divided 
into presurgical embolization in large or giant cortical 
AVMs and embolization before radiosurgical intervention 
to reduce nidus size. In addition, palliative embolization 
may be used in large nonsurgical or nonradiosurgical 
AVMs in patients presenting with progressive neurological 
deficit secondary to high flow or venous hypertension. 
Feeding arteries from ventricular branches of AICA 
are difficult to expose during surgery in any posterior 
fossa approach, therefore preoperative embolization of 
these arteries is helpful.  Many posterior fossa AVMs can be treated with 
preoperative endovascular embolization to decrease the 
size and morphology of the AVM. Embolization is often 
completed in several stages to minimize the risk of 
breakthrough bleeding that can occur when a large 
volume of an AVM is embolized in a single session [34]. 
Embolization of feeding arteries from SCA may be 
indicated if SCA is dilated by increasing blood flow and it 
is the source of significant feeding arteries. If feeding 
arteries from SCA are small, it is difficult or impossible to 
selectively catheterize these vessels. In these conditions, 
proximal embolization of SCA should be avoided because 
of the risk of cerebellar stroke. Feeding arteries from 
distal SCA can be addressed surgically adjacent to the 
nidus during surgical resection of the AVM. Venous 
drainage of the AVM in this location usually goes to the 
galenic system through precentral cerebellar veins, and 
preoperative embolization of branches from SCA may 
facilitate surgical dissection of the tentorial part of the 
cerebellum. 
Except for very small AVMs, embolization before 
surgery is beneficial in the vast majority of posterior fossa 
AVMs. Technical progress in endovascular therapy allows 
relatively easy catheterization of feeding arteries, 
although the widespread use of aggressive embolization 
increased general mobidity [5,29]. In a series of 150 
patients with embolization of intracranial AVMs, Wikholm 
et al. reported a mortality rate of 1.3% and a rate of 
severe and moderate complication of 6.7% and 15.3%, 
respectively [40]. 
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Preoperative embolization has no significant utility 
in the treatment of brainstem AVMs due to the risk of 
brainstem stroke. 
 
Radiosurgery 
Stereotactic radiosurgery has become an important 
treatment technique for the management of cerebral 
AVMs. The purpose of radiosurgery is to irradiate the 
blood vessels of the AVM to cause progressive luminal 
obliteration and thereby prevent hemorrhage. 
Traditionally, radiosurgery is indicated for AVMs 
located in eloquent areas associated with high surgical 
morbidity, such as the basal nuclei and brainstem. The 
goal of radiosurgery obliteration of AVMs with nidus  
 
volume between 5 and 10 cubic cm. Complete obliteration 
is done in a latency of 1-3 years after radiosurgery in 80-
85% of cases, while the patient is not protected from 
bleeding.  
Massager et al [17] studied the results of 87 
patients with brainstem AVMs treated with gamma knife 
and showed that 95% of patients have improved or 
remained neurologically stable, with an obliteration AVM 
rate of 63% in two years and 73% in three years. These 
results lead to the following guidelines: if the surgeon is 
experienced in AVM surgery, microsurgery is an excellent 
option for superficial, pial AVMs of the brainstem, while 
radiosurgery is the best treatment for deep brainstem 
malformations.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2a  Fig. 2b 
Fig. 2d 
Fig. 2c 
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Fig. 2 Pretreatment imaging studies of a 30-year-old man with basal panventricular hemorrhage as seen in axial CT in (a),(b); 
(c) anteroposterior and (d) lateral right vertebral angiogram showed a cerebellar AVM, located within the right cerebellar 
hemisphere, with a nidus, measuring around 1,5 cm maximal diameter, with arterial feeders from the right anteroinferior cerebral 
artery and venous drainage into both lateral sinus and straight sinus; axial (e) and coronal (f) MRI scan show a small vermian, 
right paramedian, arteriovenous malformation  with minimal mass effect.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.3. MRI studies (axial, coronal and sagital scans) 
obtained in the same patient two years post gamma-knife 
treatment showing almost completely obliteration of AVM. 
 
Fig.4. Angio-MRI two years post gamma-knife 
treatment. 
 
Multimodality Treatment of posterior fossa AVMs 
AVMs are often treated by more than one treatment 
modality. This occurs in one of two fashions. It is done as 
either a planned maneuver, typically with embolization 
followed by 
surgical resection or radiosurgery, or as an 
unplanned maneuver where one treatment modality fails 
and a second treatment modality is necessary to 
obliterate the AVM. This can occur in situations such as 
residual AVM after subtotal surgical resection or resection 
of an AVM after incomplete radiosurgical treatment 
[14,23]. 
Endovascular embolization can be performed 
before surgical excision to reduce the difficulty of surgery, 
or before radiosurgery to bring the size of the lesion to the 
limits of the machine.  
Radiosurgery may be used to eradicate small 
residual disease left after craniotomy (due to technical 
difficulty or involvement of eloquent structures). 
Multidisciplinary teams will probably become 
increasingly important for optimal management of each 
individual patient. Such teams may include 
neurosurgeons, interventional neuroradiologists, and 
stereotactic radiation specialists. Continuing advances in 
microsurgical, neurointerventional, and radiosurgical 
techniques will affect treatment approaches.  
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Conclusion 
Posterior fossa AVMs deserve multimodality 
intervention when feasible in most cases because of their 
higher risk of rupture and higher potential for morbidity 
and mortality. Surgical resection remains the gold 
standard of therapy for treating symptomatic posterior 
fossa AVMs because it has the advantage of immediately  
 
removing the risk of hemorrhage in comparison with other 
treatment modalities. Although modern surgical 
techniques allow removal of cerebellar and superficial 
brainstem AVMs with low rates of morbidity and mortality, 
AVMs located primarily in the brainstem parenchyma are 
currently best treated with radiosurgery. Except for very 
small AVMs, embolization before surgery is beneficial in 
the vast majority of posterior fossa AVMs.   
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